Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
progesterone receptor-negative breast cancer
|
11 | 0.633 | 0.480 | 12 | 21178615 | missense variant | T/C | snv | 0.13 | 0.12 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
Hyperbilirubinemia, Neonatal
|
15 | 0.633 | 0.480 | 12 | 21178615 | missense variant | T/C | snv | 0.13 | 0.12 | 0.020 | 1.000 | 2 | 2014 | 2019 | ||||
progesterone receptor-positive breast cancer
|
17 | 0.633 | 0.480 | 12 | 21178615 | missense variant | T/C | snv | 0.13 | 0.12 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
Sex hormone binding globulin measurement
|
21 | 0.633 | 0.480 | 12 | 21178615 | missense variant | T/C | snv | 0.13 | 0.12 | 0.700 | 1.000 | 1 | 2012 | 2012 | ||||
Myalgia
|
22 | 0.633 | 0.480 | 12 | 21178615 | missense variant | T/C | snv | 0.13 | 0.12 | 0.020 | 1.000 | 2 | 2012 | 2013 | ||||
Neoplasm, Residual
|
23 | 0.633 | 0.480 | 12 | 21178615 | missense variant | T/C | snv | 0.13 | 0.12 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Hyperbilirubinemia
|
27 | 0.633 | 0.480 | 12 | 21178615 | missense variant | T/C | snv | 0.13 | 0.12 | 0.020 | 1.000 | 2 | 2013 | 2015 | ||||
Familial hypercholesterolemia - heterozygous
|
34 | 0.633 | 0.480 | 12 | 21178615 | missense variant | T/C | snv | 0.13 | 0.12 | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||
Adult Non-Hodgkin Lymphoma
|
39 | 0.633 | 0.480 | 12 | 21178615 | missense variant | T/C | snv | 0.13 | 0.12 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Childhood Non-Hodgkin Lymphoma
|
39 | 0.633 | 0.480 | 12 | 21178615 | missense variant | T/C | snv | 0.13 | 0.12 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Renal Insufficiency
|
42 | 0.633 | 0.480 | 12 | 21178615 | missense variant | T/C | snv | 0.13 | 0.12 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Thyroxine measurement
|
42 | 0.633 | 0.480 | 12 | 21178615 | missense variant | T/C | snv | 0.13 | 0.12 | 0.700 | 1.000 | 1 | 2018 | 2018 | ||||
Human immunodeficiency virus (HIV) II infection category B1
|
56 | 0.633 | 0.480 | 12 | 21178615 | missense variant | T/C | snv | 0.13 | 0.12 | 0.020 | 1.000 | 2 | 2010 | 2017 | ||||
Diarrhea
|
63 | 0.633 | 0.480 | 12 | 21178615 | missense variant | T/C | snv | 0.13 | 0.12 | 0.030 | 1.000 | 3 | 2016 | 2017 | ||||
Estradiol level result
|
75 | 0.633 | 0.480 | 12 | 21178615 | missense variant | T/C | snv | 0.13 | 0.12 | 0.700 | 1.000 | 1 | 2012 | 2012 | ||||
Estradiol measurement
|
75 | 0.633 | 0.480 | 12 | 21178615 | missense variant | T/C | snv | 0.13 | 0.12 | 0.700 | 1.000 | 1 | 2012 | 2012 | ||||
Lymphoma, Non-Hodgkin, Familial
|
79 | 0.633 | 0.480 | 12 | 21178615 | missense variant | T/C | snv | 0.13 | 0.12 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Hyperlipidemia
|
83 | 0.633 | 0.480 | 12 | 21178615 | missense variant | T/C | snv | 0.13 | 0.12 | 0.030 | 1.000 | 3 | 2010 | 2018 | ||||
Neutropenia
|
97 | 0.633 | 0.480 | 12 | 21178615 | missense variant | T/C | snv | 0.13 | 0.12 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Exudative age-related macular degeneration
|
109 | 0.633 | 0.480 | 12 | 21178615 | missense variant | T/C | snv | 0.13 | 0.12 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Thrombocytopenia
|
110 | 0.633 | 0.480 | 12 | 21178615 | missense variant | T/C | snv | 0.13 | 0.12 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Diffuse Large B-Cell Lymphoma
|
127 | 0.633 | 0.480 | 12 | 21178615 | missense variant | T/C | snv | 0.13 | 0.12 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Leukopenia
|
153 | 0.633 | 0.480 | 12 | 21178615 | missense variant | T/C | snv | 0.13 | 0.12 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Congestive heart failure
|
165 | 0.633 | 0.480 | 12 | 21178615 | missense variant | T/C | snv | 0.13 | 0.12 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Myopathy
|
166 | 0.633 | 0.480 | 12 | 21178615 | missense variant | T/C | snv | 0.13 | 0.12 | 0.790 | 1.000 | 9 | 2008 | 2019 |